VRTX

Vertex Pharmaceuticals Incorporated News Headlines

$120.05
*  
3.47
2.81%
Get VRTX Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading VRTX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
After-Hours Earnings Report for October 28, 2014 : FB, GILD, ESRX, MCK, APC, AFL, VRTX, EQR, AMP, WDC, MAR, EIX
10/28/2014 1:00:02 PM - NASDAQ.com News


Will Aegerion (AEGR) Disappoint This Earnings Season? - Analyst Blog
10/27/2014 4:40:00 PM - Zacks.com


Will Express Scripts (ESRX) Beat Q3 Earnings Estimates? - Analyst Blog
10/27/2014 12:32:00 PM - Zacks.com


Should You Buy Vertex Pharmaceuticals (VRTX) Ahead of Earnings? - Tale of the Tape
10/27/2014 8:00:00 AM - Zacks.com


The 5 Most Expensive Drugs in the World
10/26/2014 11:21:02 AM - Motley Fool


Will Pfizer (PFE) Disappoint This Earnings Season? - Analyst Blog
10/24/2014 4:20:00 PM - Zacks.com


Will Ligand Pharmaceuticals Beat Q3 Earnings Estimates? - Analyst Blog
10/24/2014 4:00:00 PM - Zacks.com


Will Amgen (AMGN) Disappoint in the Q3 Earnings Season? - Analyst Blog
10/24/2014 3:45:00 PM - Zacks.com


Will Vertex Pharmaceuticals (VRTX) Post a Lower Q3 Loss? - Analyst Blog
10/24/2014 3:11:00 PM - Zacks.com


Will Gilead (GILD) Miss Earnings on High Operating Costs? - Analyst Blog
10/24/2014 2:39:00 PM - Zacks.com


Vertex Pharmaceuticals' Kalydeco Wins FDA Panel Backing - Analyst Blog
10/22/2014 4:54:00 PM - Zacks.com


Will Bristol-Myers (BMY) Disappoint This Earnings Season? - Analyst Blog
10/22/2014 4:00:00 PM - Zacks.com


Will Agenus (AGEN) Incur Wider-than-Expected Q3 Loss? - Analyst Blog
10/22/2014 3:30:00 PM - Zacks.com


Stock Picking Grades For Health Care Sector Fund Managers
10/22/2014 9:30:00 AM - Seeking Alpha


Is Johnson & Johnson's Worst Nightmare Becoming Reality?
10/22/2014 7:39:02 AM - Motley Fool


Pacific Biosciences to Incur Narrower-than-Expected Q3 Loss - Analyst Blog
10/21/2014 4:50:00 PM - Zacks.com


Will BioMarin (BMRN) Disappoint This Earnings Season? - Analyst Blog
10/21/2014 4:30:00 PM - Zacks.com


Will Alexion (ALXN) Earnings Suffer Due to Higher Costs? - Analyst Blog
10/21/2014 4:05:00 PM - Zacks.com


Celgene (CELG) Q3 Earnings to Be Overrun by Expenses? - Analyst Blog
10/21/2014 3:50:00 PM - Zacks.com


5 Best Biotech Stocks to Buy Now
10/21/2014 9:33:02 AM - InvestorPlace Media


Will GlaxoSmithKline (GSK) Earnings Suffer on China Probe? - Analyst Blog
10/20/2014 5:15:00 PM - Zacks.com


Will Biogen Idec (BIIB) Pull a Surprise this Earnings Season? - Analyst Blog
10/20/2014 3:45:00 PM - Zacks.com


180 Million People Have This Disease, Yet Few Are Aware of It
10/19/2014 6:47:02 AM - Motley Fool


Biotech Stock Roundup: Gilead Nabs FDA Nod for Combo HCV Drug, Auxilium Accepts Endo Offer - Analyst Blog
10/15/2014 12:59:00 PM - Zacks.com


Nasdaq 100 Movers: TSLA, VRTX
10/13/2014 12:44:02 PM - BNK Invest